Consortium on Strengthening International Collaboration
for Capitalizing on Cost-Effective and Life-Saving Commodities (i4C)
The Global Strategy Lab @ uOttawa and the Norwegian Institute of Public Health have joined forces to launch a consortium of researchers and partnering institutions focused on "Strengthening International Collaboration for Capitalizing on Cost-Effective and Life-Saving Commodities (i4C)". With a four-year operating grant of 24,662,003 Norwegian Kronor (~$4.6 million CAD) from the Research Council of Norway and additional co-funding from others, a globally integrated team is pursuing this goal by evaluating eight policy interventions directed at global health governance institutions. Five aim to improve global access to existing, life-saving commodities. These include: 1) evaluating the impact of free trade agreements and regulatory harmonization; 2) examining how emerging economies like Brazil, India and China promote access on the international stage to provide learning for other developing economies; 3) assessing advocacy strategies for promoting evidence-informed policymaking; 4) evaluating existing and new global health governance architecture's contributions to improving access; and 5) considering the role of existing and potentially new international legal mechanisms. Three aim to improve prioritization, financing and incentives for global innovation of new, life-saving commodities. This includes: 6) developing a multi-criteria priority classification model for value-based R&D investments; 7) proposing an R&D investment prioritization framework; and 8) examining how the challenge of antimicrobial resistance is deepened by existing global governance failures and how reforms can address it. These interventions represent options across all four types of global governance arrangements; international rules (#1,#5), norms and discourses (#2,#3), market interventions (#6,#7), and access to domestic policy processes (#4,#8). Building on the diverse disciplinary expertise of the research team, each intervention is evaluated using a tailored social science method that is most appropriate, whether that is economic modeling (#6-#8), interrupted time-series analyses (#1,#5), interviews and document analyses (#1,#2,#6,#7), legal analyses (#4,#5,#8), policy analyses (#4,#8), political analyses (#2,#3,#8), simulation (#7), surveys (#1,#6) or systematic reviews (#5,#7).
The consortium is led by co-principal investigators Steven J. Hoffman and John-Arne Røttingen. Core team researchers include Steinar Andresen, Dimitrios Gouglas, Berit Sofie Hembre, Trygve Ottersen, Jens Plahte, Kristin Sandberg, Lathika Sritharan and Live Storehagen. Key collaborators include Sean Caulfield, Natalie Loveless, Ole Frithjof Norheim and Mariana Prado. Key partnering institutions include the Fridtjof Nansen Institute and Harvard Global Health Institute.